Dual treatment controls agitation in one dose, study says

11/7/2012 | MedWire News (U.K.)

Agitation control was achieved in 83% of advanced cancer patients with just the first dose of haloperidol plus midazolam without significant complications, according to a study in the American Journal of Hospice and Palliative Care. Portuguese researchers called the results encouraging because most patients "were controlled in 30 minutes or less."

View Full Article in:

MedWire News (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
Boise, ID